Recursion Pharmaceuticals (NASDAQ:RXRX) Shares Down 6.1% After Insider Selling

Shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Free Report) dropped 6.1% during trading on Monday after an insider sold shares in the company. The company traded as low as $10.50 and last traded at $10.51. Approximately 3,359,534 shares traded hands during trading, a decline of 54% from the average daily volume of 7,262,308 shares. […]

Related Keywords

Christopher Gibson ,Michael Secora ,Recursion Pharmaceuticals Company Profile ,Recursion Pharmaceuticals ,Securities Exchange Commission ,Needham Company ,Nasdaq ,Recursion Pharmaceuticals Stock Performance ,Jpmorgan Chase Co ,Nvidia Corp ,News Ratings For Recursion Pharmaceuticals Daily ,Keycorp ,Institutional Trading Of Recursion Pharmaceuticals ,Sumitomo Mitsui Trust Holdings Inc ,Investment Management ,Mubadala Investment Co ,Recursion Pharmaceuticals Inc ,Get Free Report ,Exchange Commission ,Sumitomo Mitsui Trust Holdings ,Mitsui Trust Holdings ,Recursion Pharmaceuticals Daily ,Nasdaq Rxrx ,Rxrx ,Medical ,Stocks ,Technicals ,